Form 4 AI
Back to all filings

Form 4 · Filed May 20, 2026, 09:50 PM UTC

CTKB/Cytek Biosciences, Inc.

Jiang Wenbin — PRESIDENT AND CEO

AI Thesis

A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.

Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.

Transactions

12 rows
DateCodeDirectionSharesPriceValueOwned after
May 18, 2026Mother7,8545,430,537
May 18, 2026Fother1,913$4$6,7915,428,624
May 18, 2026Mother14,7335,443,357
May 18, 2026Fother3,588$4$12,7375,439,769
May 18, 2026Mother19,3345,459,103
May 18, 2026Fother5,032$4$17,8645,454,071
May 18, 2026Mother38,1415,492,212
May 18, 2026Fother15,009$4$53,2825,477,203
May 18, 2026Mother7,85439,275
May 18, 2026Mother14,733162,073
May 18, 2026Mother19,334328,696
May 18, 2026Mother38,141877,266

Source: SEC EDGAR raw filing ↗ · Accession 0001872873-26-000004

CTKB Form 4 — Jiang Wenbin — Form 4 AI